Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,931,722 papers from all fields of science
Search
Sign In
Create Free Account
Agenesis
Known as:
APLASIA
A congenital abnormality resulting in the absence of an anatomical structure.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Aplasia, NOS
CDISC SEND Non-Neoplastic Finding Type Terminology
Clinical Data Interchange Standards Consortium Terminology
Congenital absence
Narrower (1)
Congenital hypoplasia of nose
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.
M. Elliott
,
M. Litzow
,
+4 authors
M. Tallman
Blood
2007
Corpus ID: 7833962
In childhood acute lymphoblastic leukemia (ALL), a rapid decline of circulating leukemic blasts in response to induction…
Expand
Highly Cited
1993
Highly Cited
1993
Contralateral renal abnormalities in patients with renal agenesis and noncystic renal dysplasia.
B. Atiyeh
,
D. Husmann
,
M. Baum
Pediatrics
1993
Corpus ID: 32460768
The prevalence of contralateral renal abnormalities in noncystic-dysplastic kidney (NCDK) disease and renal agenesis is unknown…
Expand
Highly Cited
1992
Highly Cited
1992
Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis).
A. G. Hendrickx
,
H. Hummler
Teratology
1992
Corpus ID: 27713392
The embryotoxic and teratogenic potential of all-trans retinoic acid was assessed following exposure prior to and during early…
Expand
Highly Cited
1991
Highly Cited
1991
The biology of pure red cell aplasia.
Dessypris En
1991
Corpus ID: 89032909
1990
1990
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
W. Hiddemann
,
T. Büchner
,
+7 authors
R. Donhuijsen-Ant
Leukemia
1990
Corpus ID: 29888432
In a clinical phase II study the combination of high dose cytosine arabinoside and mitoxantrone (HAM) was applied to 24 patients…
Expand
Highly Cited
1989
Highly Cited
1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.
J. Harousseau
,
J. Reiffers
,
+6 authors
N. Ifrah
Journal of Clinical Oncology
1989
Corpus ID: 36291122
High-dose cytarabine (HDARA-C) is an effective but toxic treatment for acute myeloid leukemia (AML). In order to reduce the…
Expand
1985
1985
A randomized trial of antihuman thymocyte globulin versus murine monoclonal antihuman T-cell antibodies as immunosuppressive therapy for aplastic anemia.
K. Doney
,
P. Martin
,
+6 authors
Thomas Ed
Experimental Hematology
1985
Corpus ID: 40286515
A prospective randomized trial was undertaken to compare the efficacy and toxicity of murine antihunman T-cell monoclonal…
Expand
1982
1982
Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V).
C. Sauter
,
J. Fehr
,
P. Frick
,
J. Gmuer
,
H. Honegger
,
G. Martz
European Journal of Cancer and Clinical Oncology
1982
Corpus ID: 41700912
1981
1981
Evaluation of the ultrastructural changes in the human sertoli cell in testicular disorders and the relationship of the changes to the levels of serum FSH.
D. D. de Kretser
,
J. Kerr
,
C. Paulsen
International Journal of Andrology
1981
Corpus ID: 24959968
Sertoli cell ultrastructure was compared in men with testicular disorders (hypospermatogenesis; germ cell aplasia) and men with…
Expand
1972
1972
Mondini's deafness.
M. Paparella
,
F. el-Fiky
A M A Archives of Otolaryngology
1972
Corpus ID: 19281817
The temporal bone findings from two patients with Mondini's genetic aplastic deafness are described. Profound sensorineural…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE